As of 2025-11-01, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (6.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.97 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -333.1%.
The range of the Relative Valuation is (6.77) - (8.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 20.8x | 15.5x |
| Forward P/E multiples | 15.1x - 19.0x | 15.4x |
| Fair Price | (6.77) - (8.51) | (6.92) |
| Upside | -327.8% - -386.7% | -333.1% |
| Date | P/E |
| 2025-10-29 | -6.41 |
| 2025-10-28 | -6.78 |
| 2025-10-27 | -6.47 |
| 2025-10-24 | -6.05 |
| 2025-10-23 | -5.98 |
| 2025-10-22 | -6.07 |
| 2025-10-21 | -6.23 |
| 2025-10-20 | -6.29 |
| 2025-10-17 | -6.14 |
| 2025-10-16 | -5.91 |
| 2025-10-15 | -5.62 |
| 2025-10-14 | -6.03 |
| 2025-10-13 | -6.07 |
| 2025-10-10 | -5.65 |
| 2025-10-09 | -5.48 |
| 2025-10-08 | -5.74 |
| 2025-10-07 | -6.90 |
| 2025-10-06 | -6.96 |
| 2025-10-03 | -7.36 |
| 2025-10-02 | -6.47 |
| 2025-10-01 | -6.47 |
| 2025-09-30 | -5.91 |
| 2025-09-29 | -5.89 |
| 2025-09-26 | -5.91 |
| 2025-09-25 | -5.71 |
| 2025-09-24 | -5.42 |
| 2025-09-23 | -5.53 |
| 2025-09-22 | -5.60 |
| 2025-09-19 | -5.94 |
| 2025-09-18 | -6.14 |
| 2025-09-17 | -6.07 |
| 2025-09-16 | -6.18 |
| 2025-09-15 | -6.20 |
| 2025-09-12 | -6.34 |
| 2025-09-11 | -6.23 |
| 2025-09-10 | -5.80 |
| 2025-09-09 | -5.67 |
| 2025-09-08 | -5.60 |
| 2025-09-05 | -5.98 |
| 2025-09-04 | -5.65 |
| 2025-09-03 | -5.42 |
| 2025-09-02 | -5.18 |
| 2025-08-29 | -4.95 |
| 2025-08-28 | -4.93 |
| 2025-08-27 | -4.87 |
| 2025-08-26 | -4.89 |
| 2025-08-25 | -4.80 |
| 2025-08-22 | -4.84 |
| 2025-08-21 | -4.75 |
| 2025-08-20 | -4.58 |